A citation-based method for searching scientific literature

Mullin Ho Chung Yu, Marcus Chun Yin Chan, Claudia Ching Yan Chung, Andrew Wang Tat Li, Chara Yin Wa Yip, Christopher Chun Yu Mak, Jeffrey Fong Ting Chau, Mianne Lee, Jasmine Lee Fong Fung, Mandy Ho Yin Tsang, Joshua Chun Ki Chan, Wilfred Hing Sang Wong, Jing Yang, William Chun Ming Chui, Patrick Ho Yu Chung, Wanling Yang, So Lun Lee, Godfrey Chi Fung Chan, Paul Kwong Hang Tam, Yu Lung Lau, Clara Sze Man Tang, Kit San Yeung, Brian Hon Yin Chung. PLoS Genet 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond.
Peiqi Wang, Yun Deng, Xinyu Yan, Jianhui Zhu, Yuanyuan Yin, Yang Shu, Ding Bai, Shouyue Zhang, Heng Xu, Xiaoxi Lu. Front Genet 2020
3
100

Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
Katalin Csordas, Orsolya Lautner-Csorba, Agnes F Semsei, Andrea Harnos, Marta Hegyi, Daniel J Erdelyi, Oliver T Eipel, Csaba Szalai, Gabor T Kovacs. Br J Haematol 2014
21
100

Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.
Hiroyuki Imanishi, Noboru Okamura, Mariko Yagi, Yukari Noro, Yuka Moriya, Tsutomu Nakamura, Akira Hayakawa, Yasuhiro Takeshima, Toshiyuki Sakaeda, Masafumi Matsuo,[...]. J Hum Genet 2007
98
100

Functional consequences of genetic variations in the human organic anion transporting polypeptide 1B3 (OATP1B3) in the Korean population.
Yoon-Jee Chae, Kyeong-Ryoon Lee, Chi-Kyung Noh, Saeho Chong, Dae-Duk Kim, Chang-Koo Shim, Suk-Jae Chung. J Pharm Sci 2012
10
100



Genome-wide study of methotrexate clearance replicates SLCO1B1.
Laura B Ramsey, John C Panetta, Colton Smith, Wenjian Yang, Yiping Fan, Naomi J Winick, Paul L Martin, Cheng Cheng, Meenakshi Devidas, Ching-Hon Pui,[...]. Blood 2013
125
100

MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase.
Zachary L Taylor, Tomoyuki Mizuno, Nieko C Punt, Balaji Baskaran, Adriana Navarro Sainz, William Shuman, Nicholas Felicelli, Alexander A Vinks, Jesper Heldrup, Laura B Ramsey. Clin Pharmacol Ther 2020
10
100

Proteomics. Tissue-based map of the human proteome.
Mathias Uhlén, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardinoglu, Åsa Sivertsson, Caroline Kampf, Evelina Sjöstedt, Anna Asplund,[...]. Science 2015
100

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
100

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Rachael E Windsor, Sandra J Strauss, Constantinos Kallis, Nicholas E Wood, Jeremy S Whelan. Cancer 2012
90
100

A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
Gabrielle Lui, Jean-Marc Treluyer, Brice Fresneau, Sophie Piperno-Neumann, Nathalie Gaspar, Nadège Corradini, Jean-Claude Gentet, Perrine Marec Berard, Valérie Laurence, Pascale Schneider,[...]. J Clin Pharmacol 2018
11
100

Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
S H Cha, T Sekine, J I Fukushima , Y Kanai, Y Kobayashi, T Goya, H Endou. Mol Pharmacol 2001
402
100

Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
Susanne Radtke, Oliver Zolk, Bertold Renner, Marios Paulides, Martin Zimmermann, Anja Möricke, Martin Stanulla, Martin Schrappe, Thorsten Langer. Blood 2013
100
100

Effect of SLCO1B1 Polymorphisms on High-Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma.
Rachael R Schulte, Leena Choi, Nipun Utreja, Sara L Van Driest, C Michael Stein, Richard H Ho. Clin Transl Sci 2021
2
100

Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3).
J E Race, S M Grassl, W J Williams, E J Holtzman. Biochem Biophys Res Commun 1999
124
100

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Andrés J M Ferreri, Michele Reni, Marco Foppoli, Maurizio Martelli, Gerasimus A Pangalis, Maurizio Frezzato, Maria Giuseppina Cabras, Alberto Fabbri, Gaetano Corazzelli, Fiorella Ilariucci,[...]. Lancet 2009
390
100

Effect of the Polymorphism of Folylpolyglutamate Synthetase on Treatment of High-Dose Methotrexate in Pediatric Patients with Acute Lymphocytic Leukemia.
Zhen Huang, Hong-Fei Tong, Yuan Li, Jiang-Chao Qian, Ju-Xiang Wang, Zhe Wang, Ji-Chen Ruan. Med Sci Monit 2016
11
100

Influence of Methylenetetrahydrofolate Reductase C677T, A1298C, and G80A Polymorphisms on the Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Dayse Maria Vasconcelos de Deus, Elker Lene Santos de Lima, Rafaela Maria Seabra Silva, Edinalva Pereira Leite, Maria Tereza Cartaxo Muniz. Leuk Res Treatment 2012
20
100

Preventing and Managing Toxicities of High-Dose Methotrexate.
Scott C Howard, John McCormick, Ching-Hon Pui, Randall K Buddington, R Donald Harvey. Oncologist 2016
248
100

Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
Ewelina Kałużna, Ewa Strauss, Olga Zając-Spychała, Ewelina Gowin, Bogna Świątek-Kościelna, Jerzy Nowak, Marta Fichna, Przemysław Mańkowski, Danuta Januszkiewicz-Lewandowska. Eur J Pharmacol 2015
22
100

Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
Shu-mei Wang, Lu-lu Sun, Wei-xin Zeng, Wan-shui Wu, Guo-liang Zhang. Cancer Chemother Pharmacol 2014
13
100

Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.
Maria L H Vlaming, Zeliha Pala, Anita van Esch, Els Wagenaar, Olaf van Tellingen, Dirk R de Waart, Ronald P J Oude Elferink, Koen van de Wetering, Alfred H Schinkel. Clin Cancer Res 2008
49
100


Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL).
Rizal Husaini Razali, Mohd Nur Fakhruzzaman Noorizhab, Hisyam Jamari, Richard Johari James, Kok Hoi Teh, Hishamshah Mohd Ibrahim, Lay Kek Teh, Mohd Zaki Salleh. Pediatr Hematol Oncol 2020
9
100

Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy.
Masakatsu Yanagimachi, Hiroaki Goto, Tetsuji Kaneko, Takuya Naruto, Koji Sasaki, Masanobu Takeuchi, Reo Tanoshima, Hiromi Kato, Tomoko Yokosuka, Ryosuke Kajiwara,[...]. Int J Hematol 2013
20
100

Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Lobna Ben Mahmoud, Moez Mdhaffar, Rim Frikha, Hanen Ghozzi, Ahmed Hakim, Zouheir Sahnoun, Moez Elloumi, Khaled Zeghal. Adv Clin Exp Med 2018
12
100

The clinical pharmacology of methotrexate.
J H Schornagel, J G McVie. Cancer Treat Rev 1983
109
100



Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
Winfried H Alsdorf, Panagiotis Karagiannis, Claudia Langebrake, Carsten Bokemeyer, Christian Frenzel. Oncologist 2021
1
100

Ancestry and pharmacogenetics of antileukemic drug toxicity.
Shinji Kishi, Cheng Cheng, Deborah French, Deqing Pei, Soma Das, Edwin H Cook, Nobuko Hijiya, Carmelo Rizzari, Gary L Rosner, Tony Frudakis,[...]. Blood 2007
142
100

Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia.
Yu Cheng, Mao-Hua Chen, Qian Zhuang, Bi-Juan Lin, Ying-Ying Chen, Ling Yang, Mao-Bai Liu, Wan-Cai Que, Hong-Qiang Qiu. Pediatr Blood Cancer 2021
1
100

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Marta Hegyi, Adam Arany, Agnes F Semsei, Katalin Csordas, Oliver Eipel, Andras Gezsi, Nora Kutszegi, Monika Csoka, Judit Muller, Daniel J Erdelyi,[...]. Oncotarget 2017
14
100

Treatment of acute lymphoblastic leukemia.
Ching-Hon Pui, William E Evans. N Engl J Med 2006
100

Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition.
Laura B Ramsey, Gitte H Bruun, Wenjian Yang, Lisa R Treviño, Selina Vattathil, Paul Scheet, Cheng Cheng, Gary L Rosner, Kathleen M Giacomini, Yiping Fan,[...]. Genome Res 2012
163
100

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
Magdalena Cwiklinska, Malgorzata Czogala, Kinga Kwiecinska, Anna Madetko-Talowska, Malgorzata Szafarz, Katarzyna Pawinska, Aleksandra Wieczorek, Tomasz Klekawka, Magdalena Rej, Konrad Stepien,[...]. Front Pediatr 2020
2
100

A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination.
Jean-Sébastien Hulot, Eric Villard, Ange Maguy, Véronique Morel, Lluis Mir, Isabelle Tostivint, Demiana William-Faltaos, Christine Fernandez, Stéphane Hatem, Gilbert Deray,[...]. Pharmacogenet Genomics 2005
106
100

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
Catherine Chanfreau-Coffinier, Leland E Hull, Julie A Lynch, Scott L DuVall, Scott M Damrauer, Francesca E Cunningham, Benjamin F Voight, Michael E Matheny, David W Oslin, Michael S Icardi,[...]. JAMA Netw Open 2019
36
100

Understanding and managing methotrexate nephrotoxicity.
Brigitte C Widemann, Peter C Adamson. Oncologist 2006
368
100

Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.
Jun Li, Xiao-Ru Wang, Xiao-Wen Zhai, Hong-Sheng Wang, Xiao-Wen Qian, Hui Miao, Xiao-Hua Zhu. Int J Clin Exp Med 2015
15
100

The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number.
Jannie Gregers, Ib Jarle Christensen, Kim Dalhoff, Birgitte Lausen, Henrik Schroeder, Steen Rosthoej, Niels Carlsen, Kjeld Schmiegelow, Curt Peterson. Blood 2010
58
100

Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia.
Yan Liu, You Yin, Qi Sheng, Xiaotong Lu, Fang Wang, Zhiyan Lin, Huaiping Tian, Ajing Xu, Jian Zhang. PLoS One 2014
33
100


Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate.
Yun Jung Choi, Hyangmin Park, Ji Sung Lee, Ju-Yeon Lee, Shin Kim, Tae Won Kim, Jung Sun Park, Jeong Eun Kim, Dok Hyun Yoon, Cheolwon Suh. Hematol Oncol 2017
8
100

Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics.
P T Ravi Rajagopalan, Zhiquan Zhang, Lynn McCourt, Mary Dwyer, Stephen J Benkovic, Gordon G Hammes. Proc Natl Acad Sci U S A 2002
176
100


In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
Michael J Sorich, Nicolas Pottier, Deqing Pei, Wenjian Yang, Leo Kager, Gabriele Stocco, Cheng Cheng, John C Panetta, Ching-Hon Pui, Mary V Relling,[...]. PLoS Med 2008
57
100

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.
Nikola Kotur, Jelena Lazic, Bojan Ristivojevic, Biljana Stankovic, Vladimir Gasic, Lidija Dokmanovic, Nada Krstovski, Goran Milosevic, Dragana Janic, Branka Zukic,[...]. Genes (Basel) 2020
4
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.